Dual Toxic-Peptide-Coding Staphylococcus aureus RNA under Antisense Regulation Targets Host Cells and Bacterial Rivals Unequally

Cell Reports

Volumn 7, Issue 2, 2014, Pages 424-435

  Pinel Marie, Marie Laure ^a   Brielle, Régine ^a   Felden, Brice ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; TRANSFER RNA; BACTERIAL TOXIN; MESSENGER RNA; OUTER MEMBRANE PROTEIN;

ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELLULAR DISTRIBUTION; CODON; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; RIBOSOME; SPRF1 GENE; SPRG1 GENE; STAPHYLOCOCCUS AUREUS; TRANSLATION INITIATION; AMINO ACID SEQUENCE; DRUG EFFECTS; ERYTHROCYTE; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PATHOGENICITY; PSEUDOMONAS AERUGINOSA; SPECIES DIFFERENCE; TOXICITY;

AMINO ACID SEQUENCE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TOXINS; ERYTHROCYTES; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; RNA, ANTISENSE; RNA, MESSENGER; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 84899628221     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.012     Document Type: Article

References (51)

1. Alix E., Blanc-Potard A.B. Hydrophobic peptides: novel regulators within bacterial membrane. Mol. Microbiol. 2009, 72:5-11.
2. Anstead G.M., Cadena J., Javeri H. Treatment of infections due to resistant Staphylococcus aureus. Methods Mol. Biol. 2014, 1085:259-309.
3. Antal M., Bordeau V., Douchin V., Felden B. A small bacterial RNA regulates a putative ABC transporter. J.Biol. Chem. 2005, 280:7901-7908.
4. Bateman B.T., Donegan N.P., Jarry T.M., Palma M., Cheung A.L. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus invitro and invivo and its application in demonstrating the role of sigB in microcolony formation. Infect. Immun. 2001, 69:7851-7857.
5. Bayer M.G., Heinrichs J.H., Cheung A.L. The molecular architecture of the sar locus in Staphylococcus aureus. J.Bacteriol. 1996, 178:4563-4570.
6. Blower T.R., Salmond G.P., Luisi B.F. Balancing at survival's edge: the structure and adaptive benefits of prokaryotic toxin-antitoxin partners. Curr. Opin. Struct. Biol. 2011, 21:109-118.
7. Brantl S. Bacterial type I toxin-antitoxin systems. RNA Biol. 2012, 9:1488-1490.
8. Brückner R. Gene replacement in Staphylococcus carnosus and Staphylococcus xylosus. FEMS Microbiol. Lett. 1997, 151:1-8.
9. Caldelari I., Chao Y., Romby P., Vogel J. RNA-mediated regulation in pathogenic bacteria. Cold Spring Harb. Perspect. Med. 2013, 3:a010298.
10. Caron M.P., Bastet L., Lussier A., Simoneau-Roy M., Massé E., Lafontaine D.A. Dual-acting riboswitch control of translation initiation and mRNA decay. Proc. Natl. Acad. Sci. USA 2012, 109:E3444-E3453.
11. Chabelskaya S., Gaillot O., Felden B. A Staphylococcus aureus small RNA is required for bacterial virulence and regulates the expression of an immune-evasion molecule. PLoS Pathog. 2010, 6:e1000927.
12. Charpentier E., Anton A.I., Barry P., Alfonso B., Fang Y., Novick R.P. Novel cassette-based shuttle vector system for gram-positive bacteria. Appl. Environ. Microbiol. 2004, 70:6076-6085.
13. Cheung G.Y., Duong A.C., Otto M. Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. Microbes Infect. 2012, 14:380-386.
14. Dörr T., Vulić M., Lewis K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 2010, 8:e1000317.
15. Downer R., Roche F., Park P.W., Mecham R.P., Foster T.J. The elastin-binding protein of Staphylococcus aureus (EbpS) is expressed at the cell surface as an integral membrane protein and not as a cell wall-associated protein. J.Biol. Chem. 2002, 277:243-250.
16. Fozo E.M. New type I toxin-antitoxin families from "wild" and laboratory strains of E. coli: Ibs-Sib, ShoB-OhsC and Zor-Orz. RNA Biol. 2012, 9:1504-1512.
17. Fozo E.M., Makarova K.S., Shabalina S.A., Yutin N., Koonin E.V., Storz G. Abundance of type I toxin-antitoxin systems in bacteria: searches for new candidates and discovery of novel families. Nucleic Acids Res. 2010, 38:3743-3759.
18. Guillet J., Hallier M., Felden B. Emerging functions for the Staphylococcus aureus RNome. PLoS Pathog. 2013, 9:e1003767.
19. Gurnev P.A., Ortenberg R., Dörr T., Lewis K., Bezrukov S.M. Persister-promoting bacterial toxin TisB produces anion-selective pores in planar lipid bilayers. FEBS Lett. 2012, 586:2529-2534.
20. Haggar A., Shannon O., Norrby-Teglund A., Flock J.I. Dual effects of extracellular adherence protein from Staphylococcus aureus on peripheral blood mononuclear cells. J.Infect. Dis. 2005, 15:210-217.
21. Hancock R.E., Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 2002, 206:143-149.
22. Holcík M., Iyer V.N. Conditionally lethal genes associated with bacterial plasmids. Microbiology 1997, 143:3403-3416.
23. Izard J.W., Doughty M.B., Kendall D.A. Physical and conformational properties of synthetic idealized signal sequences parallel their biological function. Biochemistry 1995, 34:9904-9912.
24. Jahn N., Brantl S. One antitoxin-two functions: SR4 controls toxin mRNA decay and translation. Nucleic Acids Res. 2013, 41:9870-9880.
25. Jahn N., Preis H., Wiedemann C., Brantl S. BsrG/SR4 from Bacillus subtilis-the first temperature-dependent type I toxin-antitoxin system. Mol. Microbiol. 2012, 83:579-598.
26. Jorgensen J.H., Ferraro M.J. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin. Infect. Dis. 2009, 49:1749-1755.
27. Li G.W., Oh E., Weissman J.S. The anti-Shine-Dalgarno sequence drives translational pausing and codon choice in bacteria. Nature 2012, 484:538-541.
28. Mann B., van Opijnen T., Wang J., Obert C., Wang Y.D., Carter R., McGoldrick D.J., Ridout G., Camilli A., Tuomanen E.I., Rosch J.W. Control of virulence by small RNAs in Streptococcus pneumoniae. PLoS Pathog. 2012, 8:e1002788.
29. Mellin J.R., Cossart P. The non-coding RNA world of the bacterial pathogen Listeria monocytogenes. RNA Biol. 2012, 9:372-378.
30. Nishizawa A., Nakayama M., Uemura T., Fukuda Y., Kimura S. Ribosome-binding site interference caused by Shine-Dalgarno-like nucleotide sequences in Escherichia coli cells. J.Biochem. 2010, 147:433-443.
31. Novick R.P., Geisinger E. Quorum sensing in staphylococci. Annu. Rev. Genet. 2008, 42:541-564.
32. Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu. Rev. Microbiol. 2010, 64:143-162.
33. Park S.Y., Cromie M.J., Lee E.J., Groisman E.A. A bacterial mRNA leader that employs different mechanisms to sense disparate intracellular signals. Cell 2010, 142:737-748.
34. Periasamy S., Joo H.S., Duong A.C., Bach T.H., Tan V.Y., Chatterjee S.S., Cheung G.Y., Otto M. How Staphylococcus aureus biofilms develop their characteristic structure. Proc. Natl. Acad. Sci. USA 2012, 109:1281-1286.
35. Pichon C., Felden B. Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains. Proc. Natl. Acad. Sci. USA 2005, 102:14249-14254.
36. Ravn P., Arnau J., Madsen S.M., Vrang A., Israelsen H. Optimization of signal peptide SP310 for heterologous protein production in Lactococcus lactis. Microbiology 2003, 149:2193-2201.
37. Roberts C., Anderson K.L., Murphy E., Projan S.J., Mounts W., Hurlburt B., Smeltzer M., Overbeek R., Disz T., Dunman P.M. Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives. J.Bacteriol. 2006, 188:2593-2603.
38. Romilly C., Chevalier C., Marzi S., Masquida B., Geissmann T., Vandenesch F., Westhof E., Romby P. Loop-loop interactions involved in antisense regulation are processed by the endoribonuclease III in Staphylococcus aureus. RNA Biol. 2012, 9:1461-1472.
39. Sayed N., Jousselin A., Felden B. A cis-antisense RNA acts intrans in Staphylococcus aureus to control translation of a human cytolytic peptide. Nat. Struct. Mol. Biol. 2012, 19:105-112.
40. Sayed N., Nonin-Lecomte S., Réty S., Felden B. Functional andstructural insights of a Staphylococcus aureus apoptotic-like membrane peptide from a toxin-antitoxin module. J.Biol. Chem. 2012, 287:43454-43463.
41. Seol J.H., Yoo S.J., Kim K.I., Kang M.S., Ha D.B., Chung C.H. The 65-kDa protein derived from the internal translational initiation site of theclpA gene inhibits the ATP-dependent protease Ti in Escherichia coli. J.Biol. Chem. 1994, 269:29468-29473.
42. Storz G., Vogel J., Wassarman K.M. Regulation by small RNAs in bacteria: expanding frontiers. Mol. Cell 2011, 43:880-891.
43. Takimura Y., Kato M., Ohta T., Yamagata H., Udaka S. Secretion of human interleukin-2 in biologically active form by Bacillus brevis directly into culture medium. Biosci. Biotechnol. Biochem. 1997, 61:1858-1861.
44. Tomasini A., François P., Howden B.P., Fechter P., Romby P., Caldelari I. The importance of regulatory RNAs in Staphylococcus aureus. Infect. Genet. Evol. 2014, 21C:616-626.
45. Tsuchihashi Z., Kornberg A. Translational frameshifting generates the gamma subunit of DNA polymerase III holoenzyme. Proc. Natl. Acad. Sci. USA 1990, 87:2516-2520.
46. Van Melderen L. Toxin-antitoxin systems: why so many, what for?. Curr. Opin. Microbiol. 2010, 13:781-785.
47. Vanderpool C.K., Balasubramanian D., Lloyd C.R. Dual-function RNA regulators in bacteria. Biochimie 2011, 93:1943-1949.
48. Wang R., Braughton K.R., Kretschmer D., Bach T.H., Queck S.Y., Li M., Kennedy A.D., Dorward D.W., Klebanoff S.J., Peschel A., et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 2007, 13:1510-1514.
49. Williams J.J., Hergenrother P.J. Artificial activation of toxin-antitoxin systems as an antibacterial strategy. Trends Microbiol. 2012, 20:291-298.
50. Zecconi A., Scali F. Staphylococcus aureus virulence factors inevasion from innate immune defenses in human and animal diseases. Immunol. Lett. 2013, 150:12-22.
51. Zeghouf M., Li J., Butland G., Borkowska A., Canadien V., Richards D., Beattie B., Emili A., Greenblatt J.F. Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes. J.Proteome Res. 2004, 3:463-468.